These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 33596357

  • 1. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
    Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HOD, Li Y, McKain L, Arjona Ferreira JC, Langenberg AGM, Wagman RB, Stewart EA.
    N Engl J Med; 2021 Feb 18; 384(7):630-642. PubMed ID: 33596357
    [Abstract] [Full Text] [Related]

  • 2. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
    Stewart EA, Al-Hendy A, Lukes AS, Madueke-Laveaux OS, Zhu E, Proehl S, Schulmann T, Marsh EE.
    Am J Obstet Gynecol; 2024 Feb 18; 230(2):237.e1-237.e11. PubMed ID: 37863160
    [Abstract] [Full Text] [Related]

  • 3. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
    Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A.
    Am J Obstet Gynecol; 2023 Mar 18; 228(3):320.e1-320.e11. PubMed ID: 36370871
    [Abstract] [Full Text] [Related]

  • 4. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
    Al-Hendy A, Venturella R, Arjona Ferreira JC, Li Y, Soulban G, Wagman RB, Lukes AS.
    Am J Obstet Gynecol; 2023 Dec 18; 229(6):662.e1-662.e25. PubMed ID: 37666383
    [Abstract] [Full Text] [Related]

  • 5. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
    Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA.
    Obstet Gynecol; 2022 Dec 01; 140(6):920-930. PubMed ID: 36357960
    [Abstract] [Full Text] [Related]

  • 6. Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials.
    Stewart EA, Lukes AS, Venturella R, Arjona Ferreira JC, Li Y, Hunsche E, Wagman RB, Al-Hendy A.
    Obstet Gynecol; 2022 Jun 01; 139(6):1070-1081. PubMed ID: 35675604
    [Abstract] [Full Text] [Related]

  • 7. Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.
    Osuga Y, Enya K, Kudou K, Tanimoto M, Hoshiai H.
    Obstet Gynecol; 2019 Mar 01; 133(3):423-433. PubMed ID: 30741797
    [Abstract] [Full Text] [Related]

  • 8. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.
    Obstet Gynecol; 2018 Nov 01; 132(5):1252-1264. PubMed ID: 30303923
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A plain language summary of the long-term relugolix combination therapy study for uterine fibroids.
    Al-Hendy A, Lukes AS, Venturella R, Villarroel C, McKain L, Li Y, Wagman RB, Stewart EA.
    J Comp Eff Res; 2023 Aug 01; 12(8):e230069. PubMed ID: 37477173
    [Abstract] [Full Text] [Related]

  • 11. Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials.
    Venturella R, Rechberger T, Zatik J, Wagman RB, Zhu E, Rakov VG, Petraglia F.
    Gynecol Endocrinol; 2023 Aug 17; 39(1):2249107. PubMed ID: 37634528
    [Abstract] [Full Text] [Related]

  • 12. A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.
    Al-Hendy A, Lukes AS, Poindexter AN, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA.
    Pain Manag; 2023 Apr 17; 13(4):205-211. PubMed ID: 37183454
    [Abstract] [Full Text] [Related]

  • 13. Myfembree for fibroid-associated heavy menstrual bleeding.
    Med Lett Drugs Ther; 2021 Aug 09; 63(1630):121-123. PubMed ID: 34550666
    [No Abstract] [Full Text] [Related]

  • 14. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
    Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O.
    N Engl J Med; 2020 Jan 23; 382(4):328-340. PubMed ID: 31971678
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
    Stewart EA, Diamond MP, Williams ARW, Carr BR, Myers ER, Feldman RA, Elger W, Mattia-Goldberg C, Schwefel BM, Chwalisz K.
    Hum Reprod; 2019 Apr 01; 34(4):623-634. PubMed ID: 30865281
    [Abstract] [Full Text] [Related]

  • 16. An evaluation of relugolix/estradiol/norethindrone acetate for the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.
    Ali M, Chen HY, Chiang YF, Badary OA, Hsia SM, Al-Hendy A.
    Expert Opin Pharmacother; 2022 Mar 01; 23(4):421-429. PubMed ID: 35068291
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
    Osuga Y, Enya K, Kudou K, Hoshiai H.
    Fertil Steril; 2019 Nov 01; 112(5):922-929.e2. PubMed ID: 31594635
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.